Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4398959)

Published in J Diabetes Res on April 02, 2015

Authors

Isabel Moreno-Indias1, Francisco José Tinahones1

Author Affiliations

1: Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria), Universidad de Málaga, 29010 Málaga, Spain ; Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain.

Articles cited by this

(truncated to the top 100)

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33

Abdominal obesity and metabolic syndrome. Nature (2006) 14.20

Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12

Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet (1962) 13.72

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88

Dynamics of fat cell turnover in humans. Nature (2008) 9.80

Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol (2006) 6.85

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes (2007) 6.81

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes (1998) 6.53

Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A (2002) 6.00

Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev (2009) 4.35

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science (2010) 4.15

The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol (2013) 3.51

Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays (2002) 3.22

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. Biochim Biophys Acta (2010) 3.19

Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) (2008) 3.17

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol (2010) 2.90

Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta (2009) 2.84

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72

Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev (1995) 2.59

Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis (2013) 2.33

Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res (2007) 2.25

The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav (2007) 2.23

Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab (2013) 2.21

Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism. J Biol Chem (2005) 2.15

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov (2010) 2.14

The obese healthy paradox: is inflammation the answer? Biochem J (2010) 2.14

Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes (2009) 2.11

Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. J Nutr (2004) 2.00

Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes (2012) 1.95

Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91

Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol (2008) 1.88

American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol (2014) 1.86

Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci U S A (2008) 1.80

Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med (2014) 1.69

It's not how fat you are, it's what you do with it that counts. PLoS Biol (2008) 1.69

The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab (2012) 1.66

Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60

Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. Cell Metab (2012) 1.54

Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol (2012) 1.49

Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol (2012) 1.49

TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. Clin Sci (Lond) (2012) 1.49

From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis (2009) 1.49

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) (2007) 1.49

Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans (2008) 1.45

Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38

Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia (2010) 1.37

Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol (2014) 1.35

Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep (2004) 1.33

Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab (2013) 1.27

Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim Biophys Acta (2009) 1.27

Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol (2011) 1.26

Mechanisms of insulin resistance in obesity. Front Med (2013) 1.26

Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim Biophys Acta (2004) 1.24

De novo lipogenesis in health and disease. Metabolism (2014) 1.20

Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem (2008) 1.18

Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes (2008) 1.16

Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr (2010) 1.15

Fat cell turnover in humans. Biochem Biophys Res Commun (2010) 1.15

Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg (2010) 1.14

Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes (2011) 1.14

Hormonal and nutritional regulation of SCD1 gene expression. Biochimie (2010) 1.14

Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J (2009) 1.13

The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) (2009) 1.12

Body fat distribution and insulin resistance. Nutrients (2013) 1.11

Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf) (2014) 1.11

Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab (2012) 1.09

Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects. PLoS One (2011) 1.05

Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord (2004) 1.05

Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects. Mol Med (2010) 1.05

Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol Med (2011) 1.04

Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol (2012) 1.02

Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J (2011) 1.00

Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab (2013) 1.00

IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology (2010) 0.99

The role of gut microbiota on insulin resistance. Nutrients (2013) 0.99

Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev (2014) 0.98

PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity (Silver Spring) (2009) 0.97

Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Cytokine (2006) 0.96

Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes (Lond) (2010) 0.96

Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res (2012) 0.95

Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab (2013) 0.94

Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS One (2011) 0.94

Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab (2010) 0.94

Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Mol Endocrinol (2011) 0.93

An inflammatory micro-environment promotes human adipocyte apoptosis. Mol Cell Endocrinol (2011) 0.93

Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int J Obes (Lond) (2006) 0.92

Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients. PLoS One (2012) 0.90

Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes (2013) 0.89

PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest (2009) 0.88

FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS One (2012) 0.88

TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma. Cell Death Dis (2013) 0.88

Peroxisome proliferator-activated receptor γ-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol (2012) 0.87

Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration. Diabetes Care (2012) 0.85

ACCA phosphopeptide recognition by the BRCT repeats of BRCA1. J Mol Biol (2006) 0.85

The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNFα. J Clin Endocrinol Metab (2013) 0.84

On the TRAIL of obesity and diabetes. Trends Endocrinol Metab (2013) 0.84

Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects. PLoS One (2012) 0.83

Thyroid hormone responsive Spot 14 increases during differentiation of human adipocytes and its expression is down-regulated in obese subjects. Int J Obes (Lond) (2009) 0.83

Inverse relation between FASN expression in human adipose tissue and the insulin resistance level. Nutr Metab (Lond) (2010) 0.83